Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy

Abstract

Metastasectomy for melanoma is associated with improved OS in patients that respond to targeted molecular or immunotherapy. Resection should be strongly considered in this cohort as multimodality treatment results in excellent OS.